EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal Stem Cells Derived from Different Sources and Their Secretome in Multiple Sclerosis Therapy: A Single Center Experience

Samar Abbas, Alain Chebly, Frederic Harb, Rawad Salameh, Albert Azar, Colette Hanna, Ahmad Ibrahim, Charbel Khalil

Journal of Regenerative Medicine and Biology Research · 30.04.2026 · 7 (1) · 1-9

DOI: 10.46889/jrmbr.2026.7110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Regenerative Medicine and Biology Research, online erschienen am 30.04.2026. Verfasst von Samar Abbas und 7 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple Sclerosis (MS) is a chronic autoimmune, inflammatory and demyelinating disease of the Central Nervous System (CNS), primarily affecting young adults. While current treatments can help manage symptoms, there remains a need for novel therapeutic approaches. Mesenchymal Stem Cell (MSC) therapy has emerged as a promising strategy for various neurodegenerative disorders due to its immunomodulatory properties and the therapeutic potential of its secretome. The MSC secretome comprises growth factors, cytokines and Extracellular Vesicles (EVs) that contribute to tissue repair and immune regulation. This study was conducted on 10 patients with MS over a one-year period starting in November 2023. Patients were divided into two groups: Group A received bone marrow-derived MSCs and their secretome (BM-MSCs), while Group B received Umbilical Cord-Derived MSCs (UC-MSCs). Patients in Group B demonstrated greater improvement in the Expanded Disability Status Scale (EDSS), as well as enhanced performance in speed and sustained attention indices, compared to Group A. These findings suggest that UC-MSCs may offer superior therapeutic benefits in the treatment of MS compared to BM-MSCs.

Zitieren

APA

Abbas, S., Chebly, A., Harb, F., Salameh, R., Azar, A., Hanna, C., Ibrahim, A., & Khalil, C. (2026). Mesenchymal Stem Cells Derived from Different Sources and Their Secretome in Multiple Sclerosis Therapy: A Single Center Experience. Journal of Regenerative Medicine and Biology Research, 7(1), 1-9. https://doi.org/10.46889/jrmbr.2026.7110

Vancouver

Abbas S, Chebly A, Harb F, Salameh R, Azar A, Hanna C, et al. Mesenchymal Stem Cells Derived from Different Sources and Their Secretome in Multiple Sclerosis Therapy: A Single Center Experience. Journal of Regenerative Medicine and Biology Research. 2026;7(1):1-9. doi:10.46889/jrmbr.2026.7110

BibTeX
@article{Abbas2026,
  author = {Abbas, Samar and Chebly, Alain and Harb, Frederic and Salameh, Rawad and Azar, Albert and Hanna, Colette and Ibrahim, Ahmad and Khalil, Charbel},
  title = {Mesenchymal Stem Cells Derived from Different Sources and Their Secretome in Multiple Sclerosis Therapy: A Single Center Experience},
  journal = {Journal of Regenerative Medicine and Biology Research},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {1--9},
  doi = {10.46889/jrmbr.2026.7110}
}
Kostenlos starten →